United States · Law · HR
H.R. 4771 (113th)
Designer Anabolic Steroid Control Act of 2014
Introduced
29 May 2014
Last action
18 December 2014 · Became law
Status
Became Public Law No: 113-260.
Sponsors
Rep. Pitts, Joseph R. [R-PA-16], Rep. Pallone, Frank [D-NJ-6], Jason Chaffetz, Sen. Luján, Ben Ray [D-NM], Carol Shea-Porter, Rep. Amodei, Mark E. [R-NV-2], Sen. Duckworth, Tammy [D-IL]
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Designer Anabolic Steroid Control Act of 2014 - Amends the Controlled Substances Act to: (1) expand the list of substances defined as "anabolic steroids"; (2) authorize the Attorney General to issue a temporary order adding a drug or other substance to the list of anabolic steroids; (3) impose enhanced criminal and civil penalties for possessing or trafficking in any anabolic steroid, or product containing an anabolic steroid, unless it bears a label clearly identifying the anabolic steroid by the nomenclature used by the International Union of Pure and Applied Chemistry; and (4) authorize the Attorney General to collect data and analyze products to determine whether they contain anabolic steroids and are properly labeled. Specifies that a substance shall not be considered to be a drug or hormonal substance that is considered to be an anabolic steroid if it is: (1) an herb or other botanical; (2) a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other botanical; (3) a combination of two or more such substances (i.e., botanical or concentrate, metabolite, or extract); or (4) a dietary ingredient for purposes of the Federal Food, Drug, and Cosmetic Act. Provides that any person claiming the benefit of an exemption or exception from being considered a drug or hormonal substance shall bear the burden of providing the appropriate evidence.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
29 May 2014
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
29 May 2014
Introduced
Introduced in House
Source: IntroReferral
29 May 2014
Introduced
Introduced in House
Source: IntroReferral
30 May 2014
Referred
Referred to the Subcommittee on Health.
Source: Committee
19 June 2014
Committee
Forwarded by Subcommittee to Full Committee by Voice Vote .
Source: Committee
19 June 2014
Committee
Subcommittee Consideration and Mark-up Session Held.
Source: Committee
14 July 2014
Committee
Committee Consideration and Mark-up Session Held.
Source: Committee
15 July 2014
Reported
Ordered to be Reported (Amended) by Voice Vote.
Source: Committee
15 July 2014
Committee
Committee Consideration and Mark-up Session Held.
Source: Committee
21 July 2014
Referred
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Source: Committee
9 September 2014
Committee
Subcommittee on Crime, Terrorism, Homeland Security, and Investigations Discharged.
Source: Committee
10 September 2014
Reported
Ordered to be Reported (Amended) by Voice Vote.
Source: Committee
10 September 2014
Committee
Committee Consideration and Mark-up Session Held.
Source: Committee
15 September 2014
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
15 September 2014
Passed
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7459-7460)
Source: Floor
15 September 2014
Passed
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7459-7460)
Source: Floor
15 September 2014
Floor
DEBATE - The House proceeded with forty minutes of debate on H.R. 4771.
Source: Floor
15 September 2014
Floor
Considered under suspension of the rules. (consideration: CR H7459-7461)
Source: Floor
15 September 2014
Floor
Mr. Pitts moved to suspend the rules and pass the bill, as amended.
Source: Floor
15 September 2014
Calendars
Placed on the Union Calendar, Calendar No. 434.
Source: Calendars
15 September 2014
Reported
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-587, Part I.
Source: Committee
15 September 2014
Reported
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 113-587, Part I.
Source: Committee
16 September 2014
Introduced
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Source: IntroReferral
11 December 2014
Passed
Passed Senate without amendment by Unanimous Consent.
Source: Floor
11 December 2014
Passed
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Source: Floor
11 December 2014
Discharge
Senate Committee on the Judiciary discharged by Unanimous Consent. (consideration: CR S6696)
Source: Discharge
11 December 2014
Committee
Senate Committee on the Judiciary discharged by Unanimous Consent.(consideration: CR S6696)
Source: Committee
12 December 2014
Floor
Message on Senate action sent to the House.
Source: Floor
13 December 2014
Floor
Presented to President.
Source: Floor
13 December 2014
President
Presented to President.
Source: President
18 December 2014
President
Signed by President.
Source: President
18 December 2014
Became law
Became Public Law No: 113-260.
Source: President
18 December 2014
Became law
Signed by President.
Source: BecameLaw
Votes
No vote records are attached yet.
Versions
- Enrolled Bill · undated · Official file
- Public Law · 19 December 2014 · Official file
- Referred in Senate · 16 September 2014 · Official file
- Reported in House · 15 September 2014 · Official file
- Engrossed in House · 15 September 2014 · Official file
- Introduced in House · 29 May 2014 · Official file
Documents
16 official files
Enrolled Bill (text)
Enrolled Bill (text)
Enrolled Bill · EN
Enrolled Bill (PDF)
Enrolled Bill · EN
Public Law (text)
Public Law · EN · 19 December 2014
Public Law (PDF)
Public Law · EN · 19 December 2014
Public Law
summary · EN · 18 December 2014
Passed Senate without amendment
summary · EN · 11 December 2014
Referred in Senate (text)
Referred in Senate · EN · 16 September 2014
Referred in Senate (PDF)
Referred in Senate · EN · 16 September 2014
Engrossed in House (text)
Engrossed in House · EN · 15 September 2014
Engrossed in House (PDF)
Engrossed in House · EN · 15 September 2014
Reported in House (text)
Reported in House · EN · 15 September 2014
Reported in House (PDF)
Reported in House · EN · 15 September 2014
Passed House amended
summary · EN · 15 September 2014
Introduced in House (text)
Introduced in House · EN · 29 May 2014
Introduced in House (PDF)
Introduced in House · EN · 29 May 2014
Introduced in House
summary · EN · 29 May 2014
Sponsors
- Rep. Pitts, Joseph R. [R-PA-16] · R · Sponsor
- Rep. Pallone, Frank [D-NJ-6] · D · Sponsor
- Jason Chaffetz · R · Cosponsor
- Sen. Luján, Ben Ray [D-NM] · D · Cosponsor
- Carol Shea-Porter · D · Cosponsor
- Rep. Amodei, Mark E. [R-NV-2] · R · Cosponsor
- Sen. Duckworth, Tammy [D-IL] · D · Cosponsor
- · ssju00 · Standing
- · hsju00 · Standing
- · hsif00 · Standing
Related records
- related to ← Designer Anabolic Steroid Control Act of 2014
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/113th-congress/house-bill/4771
- Open data entity: https://api.congress.gov/v3/bill/113/hr/4771
- us · 113-hr-4771 · source updated 10 August 2026